Evidence map›Paper›PMID 37717069›Full record

ArticleNature communications2023

A cleavage rule for selection of increased-fidelity SpCas9 variants with high efficiency and no detectable off-targets.

Péter István Kulcsár, András Tálas, Zoltán Ligeti, Eszter Tóth, Zsófia Rakvács, Zsuzsa Bartos, Sarah Laura Krausz, Ágnes Welker, Vanessza Laura Végi, Krisztina Huszár and 1 more

Abstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Epigenetic editing: from concept to clinic.Nature reviews. Drug discovery · 2026
    Review
  4. Article
  5. Recent Advances in Tomato Gene Editing.International journal of molecular sciences · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Péter István KulcsárInstitute of Enzymology, Research Centre for Natural Sciences, Budapest, Hungary.ORCID http://orcid.org/0000-0002-7783-5108
András TálasInstitute of Enzymology, Research Centre for Natural Sciences, Budapest, Hungary.
Zoltán LigetiInstitute of Enzymology, Research Centre for Natural Sciences, Budapest, Hungary.ORCID http://orcid.org/0009-0002-0055-230X
Eszter TóthInstitute of Enzymology, Research Centre for Natural Sciences, Budapest, Hungary.
Zsófia RakvácsInstitute of Enzymology, Research Centre for Natural Sciences, Budapest, Hungary.
Zsuzsa BartosInstitute of Enzymology, Research Centre for Natural Sciences, Budapest, Hungary.ORCID http://orcid.org/0000-0001-9695-1422
Sarah Laura KrauszInstitute of Enzymology, Research Centre for Natural Sciences, Budapest, Hungary.
Ágnes WelkerInstitute of Cognitive Neuroscience and Psychology, Research Centre for Natural Sciences, Budapest, Hungary.
Vanessza Laura VégiInstitute of Enzymology, Research Centre for Natural Sciences, Budapest, Hungary.
Krisztina HuszárInstitute of Enzymology, Research Centre for Natural Sciences, Budapest, Hungary.
Ervin WelkerInstitute of Enzymology, Research Centre for Natural Sciences, Budapest, Hungary. welker.ervin@ttk.hu.ORCID http://orcid.org/0000-0001-9874-8794

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Streptococcus pyogenes Cas9 (SpCas9) has been employed as a genome engineering tool with a promising potential within therapeutics. However, its off-target effects present major safety concerns for applications requiring high specificity. Approaches developed to date to mitigate this effect, including any of the increased-fidelity (i.e., high-fidelity) SpCas9 variants, only provide efficient editing on a relatively small fraction of targets without detectable off-targets. Upon addressing this problem, we reveal a rather unexpected cleavability ranking of target sequences, and a cleavage rule that governs the on-target and off-target cleavage of increased-fidelity SpCas9 variants but not that of SpCas9-NG or xCas9. According to this rule, for each target, an optimal variant with matching fidelity must be identified for efficient cleavage without detectable off-target effects. Based on this insight, we develop here an extended set of variants, the CRISPRecise set, with increased fidelity spanning across a wide range, with differences in fidelity small enough to comprise an optimal variant for each target, regardless of its cleavability ranking. We demonstrate efficient editing with maximum specificity even on those targets that have not been possible in previous studies.

Indexed as

EngineeringStreptococcus pyogenes

Identifiers

PMID37717069
PMCPMC10505190

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.